BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8385540)

  • 1. Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviors in a rat model of peripheral mononeuropathy.
    Mao J; Price DD; Hayes RL; Lu J; Mayer DJ; Frenk H
    Brain Res; 1993 Mar; 605(1):164-8. PubMed ID: 8385540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy.
    Mao J; Price DD; Hayes RL; Lu J; Mayer DJ
    Brain Res; 1992 Dec; 598(1-2):271-8. PubMed ID: 1362520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal GM1 ganglioside and local nerve anesthesia reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy.
    Mao J; Price DD; Hayes RL; Lu J; Mayer DJ
    Brain Res; 1992 Jul; 584(1-2):28-53. PubMed ID: 1325247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal MK-801 and local nerve anesthesia synergistically reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy.
    Mao J; Price DD; Mayer DJ; Lu J; Hayes RL
    Brain Res; 1992 Apr; 576(2):254-62. PubMed ID: 1325239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dextrorphan relieves neuropathic heat-evoked hyperalgesia in the rat.
    Tal M; Bennett GJ
    Neurosci Lett; 1993 Mar; 151(1):107-10. PubMed ID: 8385757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-injury treatment with GM1 ganglioside reduces nociceptive behaviors and spinal cord metabolic activity in rats with experimental peripheral mononeuropathy.
    Mao J; Hayes RL; Price DD; Coghill RC; Lu J; Mayer DJ
    Brain Res; 1992 Jul; 584(1-2):18-27. PubMed ID: 1325244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatial patterns of increased spinal cord membrane-bound protein kinase C and their relation to increases in 14C-2-deoxyglucose metabolic activity in rats with painful peripheral mononeuropathy.
    Mao J; Mayer DJ; Hayes RL; Price DD
    J Neurophysiol; 1993 Aug; 70(2):470-81. PubMed ID: 8410149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Suppressive effects of ketamine on neuropathic pain].
    Sonoda H; Omote K
    Masui; 1998 Feb; 47(2):136-44. PubMed ID: 9513324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preemptive intrathecal ketamine injection produces a long-lasting decrease in neuropathic pain behaviors in a rat model.
    Burton AW; Lee DH; Saab C; Chung JM
    Reg Anesth Pain Med; 1999; 24(3):208-13. PubMed ID: 10338169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathic pain sensations are differentially sensitive to dextrorphan.
    Tal M; Bennett GJ
    Neuroreport; 1994 Jul; 5(12):1438-40. PubMed ID: 7948833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat.
    Chaplan SR; Malmberg AB; Yaksh TL
    J Pharmacol Exp Ther; 1997 Feb; 280(2):829-38. PubMed ID: 9023297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal lithium reduces neuropathic pain responses in a rat model of peripheral neuropathy.
    Shimizu T; Shibata M; Wakisaka S; Inoue T; Mashimo T; Yoshiya I
    Pain; 2000 Mar; 85(1-2):59-64. PubMed ID: 10692603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of norketamine enantiomers in rodent models of persistent pain.
    Holtman JR; Crooks PA; Johnson-Hardy JK; Hojomat M; Kleven M; Wala EP
    Pharmacol Biochem Behav; 2008 Oct; 90(4):676-85. PubMed ID: 18586315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preemptive intrathecal ketamine delays mechanical hyperalgesia in the neuropathic rat.
    Hartrick CT; Wise JJ; Patterson JS
    Anesth Analg; 1998 Mar; 86(3):557-60. PubMed ID: 9495414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic ketamine attenuates nociceptive behaviors in a rat model of peripheral neuropathy.
    Qian J; Brown SD; Carlton SM
    Brain Res; 1996 Apr; 715(1-2):51-62. PubMed ID: 8739622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of A-317491, a novel and selective P2X3/P2X2/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration.
    McGaraughty S; Wismer CT; Zhu CZ; Mikusa J; Honore P; Chu KL; Lee CH; Faltynek CR; Jarvis MF
    Br J Pharmacol; 2003 Dec; 140(8):1381-8. PubMed ID: 14623769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperbaric oxygenation therapy alleviates chronic constrictive injury-induced neuropathic pain and reduces tumor necrosis factor-alpha production.
    Li F; Fang L; Huang S; Yang Z; Nandi J; Thomas S; Chen C; Camporesi E
    Anesth Analg; 2011 Sep; 113(3):626-33. PubMed ID: 21596875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraplantar injection of dextrorphan, ketamine or memantine attenuates formalin-induced behaviors.
    Davidson EM; Carlton SM
    Brain Res; 1998 Feb; 785(1):136-42. PubMed ID: 9526066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment with gangliosides reduces abnormal nociceptive responses associated with a rodent peripheral mononeuropathy.
    Hayes RL; Mao J; Price DD; Germano A; d'Avella D; Fiori M; Mayer DJ
    Pain; 1992 Mar; 48(3):391-396. PubMed ID: 1317543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal administration of NTS1 agonists reverses nociceptive behaviors in a rat model of neuropathic pain.
    Guillemette A; Dansereau MA; Beaudet N; Richelson E; Sarret P
    Eur J Pain; 2012 Apr; 16(4):473-84. PubMed ID: 22396077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.